Investigación > Enfermedades crónicas, Cirugía y Cuidado de la Salud

Grupo de investigación traslacional vascular y renal

Número de publicaciones
415
Buscador de publicaciones
  • Lopez-Cano, C; Rius, F; Sanchez, E; Gaeta, AM; Betriu À; Fernandez, E; Yeramian, A; Hernandez, M; Bueno, M; Gutierrez-Carrasquilla, L; Dalmases, M; Lecube, A

    The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum

    PLOS ONE 14 -. .

    [doi:10.1371/journal.pone.0211742]

  • Gutiérrez-Carrasquilla L; Sánchez E; Hernández M; Polanco D; Salas-Salvadó J; Betriu À; Gaeta AM; Carmona P; Purroy F; Pamplona R; Farràs C; López-Cano C; Fernández E; Lecube A

    Effects of Mediterranean Diet and Physical Activity on Pulmonary Function: A Cross-Sectional Analysis in the ILERVAS Project

    Nutrients 11 -. .

    [doi:10.3390/nu11020329]

  • Sarafidis, P; Ferro, CJ; Morales, E; Ortiz, A; Malyszko, J; Hojs, R; Khazim, K; Ekart, R; Valdivielso, J; Fouque, D; London, GM; Massy, Z; Ruggenenti, P; Porrini, E; Wiecek, A; Zoccali, C; Mallamaci, F; Hornum, M

    SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

    NEPHROLOGY DIALYSIS TRANSPLANTATION 34 208-230. .

    [doi:10.1093/ndt/gfy407]

  • Ferro CJ; Mark PB; Kanbay M; Sarafidis P; Heine GH; Rossignol P; Massy ZA; Mallamaci F; Valdivielso JM; Malyszko J; Verhaar MC; Ekart R; Vanholder R; London G; Ortiz A; Zoccali C

    Lipid management in patients with chronic kidney disease (vol 14, pg 727, 2018)

    NATURE REVIEWS NEPHROLOGY 15 121-121. .

    [doi:10.1038/s41581-018-0099-y]

  • Pereira, T; Betriu, A; Alves, R

    Non-invasive imaging techniques and assessment of carotid vasa vasorum neovascularization: Promises and pitfalls

    TRENDS IN CARDIOVASCULAR MEDICINE 29 71-80. .

    [doi:10.1016/j.tcm.2018.06.007]

  • Chang AR; Grams ME; Ballew SH; Bilo H; Correa A; Evans M; Gutierrez OM; Hosseinpanah F; Iseki K; Kenealy T; Klein B; Kronenberg F; Lee BJ; Li Y; Miura K; Navaneethan SD; Roderick PJ; Valdivielso JM; Visseren FLJ; Zhang L; Gansevoort RT; Hallan SI; Levey AS; Matsushita K; Shalev V; Woodward M; CKD Prognosis Consortium (CKD-PC)

    Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium

    BMJ-BRITISH MEDICAL JOURNAL 364 -. .

    [doi:10.1136/bmj.k5301]

  • Valdivielso, JM; Jacobs-Cacha, C; Soler, MJ

    Sex hormones and their influence on chronic kidney disease

    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION 28 1-9. .

    [doi:10.1097/MNH.0000000000000463]

  • Ortiz, A; Sanchez-Nino, MD; Crespo-Barrio, M; De-Sequera-Ortiz, P; Fernandez-Giraldez, E; Garcia-Maset, R; Macia-Heras, M; Perez-Fontan, M; Rodriguez-Portillo, M; Salgueira-Lazo, M; Sanchez-Alvarez, E; Santamaria-Olmo, R; Simal-Blanco, F; Pino-Pino, MD

    The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem

    Nefrologia 39 29-34. .

    [doi:10.1016/j.nefro.2018.09.002]

  • Rayego-Mateos, S; Goldschmeding, R; Ruiz-Ortega, M

    Inflammatory and Fibrotic Mediators in Renal Diseases

    Mediators of Inflammation 2019 7025251-7025251. .

    [doi:10.1155/2019/7025251]

  • Perez-Morales, RE; del Pino, M; Valdivielso, JM; Ortiz, A; Mora-Fernandez, C; Navarro-Gonzalez, JF

    Inflammation in Diabetic Kidney Disease

    Nephron 143 12-16. .

    [doi:10.1159/000493278]

  • Segarra, A; Martinez, C; Carnicer, C; Perich, C; Jatem, E; Martin, M

    Analytical and Biological Variability of Urinary Epidermal Growth Factor-to-Creatinine Ratio in Patients with Chronic Kidney Disease and in Healthy Volunteers

    CLINICAL LABORATORY 65 2035-2041. .

    [doi:10.7754/Clin.Lab.2019.190304]

  • Segarra, A; Carnicer, C; Jatem, E; Martin, M; Molina, M; Perich, C; Martinez, C

    Accuracy of Urinary Epidermal Growth Factor to Creatinine Ratio to Predict 24-Hour Urine Epidermal Growth Factor and Interstitial Kidney Fibrosis in Patients with IgA Nephropathy

    CLINICAL LABORATORY 65 1033-1039. .

    [doi:10.7754/Clin.Lab.2018.181122]